Effectiveness of different advanced wound dressings versus standard of care for the management of diabetic foot ulcers: a meta-analysis of randomized controlled trials for the development of the Italian guidelines for the treatment of diabetic foot syndrome.
Advanced wound dressings
Diabetic foot ulcers
Guidelines
Meta-analysis
Ulcer healing
Journal
Acta diabetologica
ISSN: 1432-5233
Titre abrégé: Acta Diabetol
Pays: Germany
ID NLM: 9200299
Informations de publication
Date de publication:
12 Jun 2024
12 Jun 2024
Historique:
received:
15
05
2024
accepted:
06
06
2024
medline:
12
6
2024
pubmed:
12
6
2024
entrez:
12
6
2024
Statut:
aheadofprint
Résumé
to assess the effects of advanced wound dressings (AWD) commonly used in the treatment of predominantly neuropathic diabetic foot ulcers (DFU) The present meta-analysis was designed to support the development of the Italian Guidelines for the Treatment of Diabetic Foot Syndrome (DFS). A Medline and Embase search were performed up to April 1st, 2024 collecting all RCTs including diabetic patients or reporting subgroup analyses on diabetic patients with DFU comparing AWD with placebo/standard of care (SoC), with a duration of at least 12 weeks. Prespecified endpoints were: ulcer healing (principal), time-to-healing, frequency of dressings change, major and minor amputation, pain, and all-cause mortality. AWD assessed were: alginates; foam, hydrocolloids, hydrogels, hyaluronic acid, hemoglobin spray, silver-impregnated, sucrose octasulfate-impregnated, honey-impregnated, micro-organism-binding, and protease-modulating matrix dressings. Mantel-Haenzel Odds ratios and 95% confidence intervals (MH-OR, 95% CIs) were either calculated or extracted directly from the publications. Weighted mean differences (WMD) and 95% CIs were calculated for continuous variables. Fifteen studies fulfilled all inclusion criteria. Participants treated with AWD had a significantly higher ulcer healing rate and shorter time-to-healing in comparison with SoC/placebo (MH-OR 1.50 [0.80, 2.79], p = 0.20 and WMD:: - 24.38 [- 42.90, - 5.86] days, p = 0.010). No other significant effect on the above reported prespecified endpoints were observed. For the primary endpoint, the quality of evidence was rated as "moderate". In conclusion, AWD, particularly sucrose-octasulfate, hydrogels, hyaluronic acid, and honey dressings, can actively promote wound healing and shortening time-to-healing in patients with DFU.
Identifiants
pubmed: 38864979
doi: 10.1007/s00592-024-02320-2
pii: 10.1007/s00592-024-02320-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. Springer-Verlag Italia S.r.l., part of Springer Nature.
Références
Aronson R, Chu L, Joseph N, Brown R (2021) Prevalence and risk evaluation of diabetic complications of the foot among adults with Type 1 and Type 2 diabetes in a large Canadian population (PEDAL Study). Can J Diabetes 45(7):588–593 (in Eng). https://doi.org/10.1016/j.jcjd.2020.11.011
doi: 10.1016/j.jcjd.2020.11.011
pubmed: 33582042
Morbach S, Furchert H, Gröblinghoff U et al (2012) Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade. Diabetes Care 35(10):2021–2027 (in Eng). https://doi.org/10.2337/dc12-0200
doi: 10.2337/dc12-0200
pubmed: 22815299
pmcid: 3447849
Elgzyri T, Larsson J, Nyberg P, Thörne J, Eriksson KF, Apelqvist J (2014) Early revascularization after admittance to a diabetic foot center affects the healing probability of ischemic foot ulcer in patients with diabetes. Eur J Vasc Endovasc Surg 48(4):440–446 (in Eng). https://doi.org/10.1016/j.ejvs.2014.06.041
doi: 10.1016/j.ejvs.2014.06.041
pubmed: 25106090
Tan JS, Friedman NM, Hazelton-Miller C, Flanagan JP, File TM Jr (1996) Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation? Clin Infect Dis 23(2):286–291 (in Eng). https://doi.org/10.1093/clinids/23.2.286
doi: 10.1093/clinids/23.2.286
pubmed: 8842265
Meloni M, Giurato L, Monge L et al (2024) Effect of a multidisciplinary team approach in patients with diabetic foot ulcers on major adverse limb events (MALEs): systematic review and meta-analysis for the development of the Italian guidelines for the treatment of diabetic foot syndrome. Acta Diabetol (in Eng). https://doi.org/10.1007/s00592-024-02246-9
doi: 10.1007/s00592-024-02246-9
pubmed: 38565687
Bolton L (2022) Diabetic foot ulcer: treatment challenges. Wounds 34(6):175–177 (in Eng). https://doi.org/10.25270/wnds/2022.175177 .
Edmonds M, Lázaro-Martínez JL, Alfayate-García JM et al (2018) Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial. Lancet Diabetes Endocrinol 6(3):186–196 (in Eng). https://doi.org/10.1016/s2213-8587(17)30438-2
doi: 10.1016/s2213-8587(17)30438-2
pubmed: 29275068
Martí-Carvajal AJ, Gluud C, Nicola S et al (2015) Growth factors for treating diabetic foot ulcers. Cochrane Database Syst Rev 2015(10):Cd008548 (in Eng). https://doi.org/10.1002/14651858.CD008548.pub2 .
Monami M, Scatena A, Miranda C et al (2023) Development of the Italian clinical practice guidelines for the treatment of diabetic foot syndrome: design and methodological aspects. Acta Diabetol 60(11):1449–1469 (in Eng). https://doi.org/10.1007/s00592-023-02150-8
doi: 10.1007/s00592-023-02150-8
pubmed: 37491605
Guyatt GH, Oxman AD, Santesso N et al (2013) GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes. J Clin Epidemiol 66(2):158–72 (in Eng). https://doi.org/10.1016/j.jclinepi.2012.01.012 .
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269
doi: 10.7326/0003-4819-151-4-200908180-00135
pubmed: 19622511
Higgins JP, Altman DG, Gøtzsche PC et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928 (in Eng). https://doi.org/10.1136/bmj.d5928
doi: 10.1136/bmj.d5928
pubmed: 22008217
pmcid: 3196245
Imran M, Hussain MB, Baig M (2015) A randomized, controlled clinical trial of honey-impregnated dressing for treating diabetic foot ulcer. J Coll Phys Surg Pak 25(10):721–725 (in Eng). https://doi.org/10.2015/jcpsp.721725
doi: 10.2015/jcpsp.721725
Kamaratos AV, Tzirogiannis KN, Iraklianou SA, Panoutsopoulos GI, Kanellos IE, Melidonis AI (2014) Manuka honey-impregnated dressings in the treatment of neuropathic diabetic foot ulcers. Int Wound J 11(3):259–263 (in Eng). https://doi.org/10.1111/j.1742-481X.2012.01082.x
doi: 10.1111/j.1742-481X.2012.01082.x
pubmed: 22985336
Siavash M, Shokri S, Haghighi S, Shahtalebi MA, Farajzadehgan Z (2015) The efficacy of topical royal jelly on healing of diabetic foot ulcers: a double-blind placebo-controlled clinical trial. Int Wound J 12(2):137–142 (in Eng). https://doi.org/10.1111/iwj.12063
doi: 10.1111/iwj.12063
pubmed: 23566071
Essa MS, Ahmad KS, Zayed ME, Ibrahim SG (2023) Comparative study between silver nanoparticles dressing (SilvrSTAT Gel) and conventional dressing in diabetic foot ulcer healing: a prospective randomized study. Int J Low Extrem Wounds 22(1):48–55 (in Eng). https://doi.org/10.1177/1534734620988217
doi: 10.1177/1534734620988217
pubmed: 33686887
Lafontaine N, Jolley J, Kyi M et al (2023) Prospective randomised placebo-controlled trial assessing the efficacy of silver dressings to enhance healing of acute diabetes-related foot ulcers. Diabetologia 66(4):768–776 (in Eng). https://doi.org/10.1007/s00125-022-05855-7
doi: 10.1007/s00125-022-05855-7
pubmed: 36629877
Viswanathan V, Kesavan R, Kavitha KV, Kumpatla S (2011) A pilot study on the effects of a polyherbal formulation cream on diabetic foot ulcers. Indian J Med Res 134(2):168–73 (in Eng). ( https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181016/pdf/IJMR-134-168.pdf ).
Barbosa MG, Carvalho VF, Paggiaro AO (2022) Hydrogel enriched with sodium alginate and vitamins A and E for diabetic foot ulcer: a randomized controlled trial. Wounds 34(9):229–235 (in Eng). https://doi.org/10.25270/wnds/20103 .
Djavid GE, Tabaie SM, Tajali SB et al (2020) Application of a collagen matrix dressing on a neuropathic diabetic foot ulcer: a randomised control trial. J Wound Care 29(Sup3):S13–S18 (in Eng). https://doi.org/10.12968/jowc.2020.29.Sup3.S13 .
Jeffcoate WJ, Price PE et al. Randomised controlled trial of the use of three dressing preparations in the management of chronic ulceration of the foot in diabetes. Health Technol Assess 2009;13(54):1–86, iii–iv (in Eng). https://doi.org/10.3310/hta13540 .
Piaggesi A, Baccetti F, Rizzo L, Romanelli M, Navalesi R, Benzi L (2001) Sodium carboxyl-methyl-cellulose dressings in the management of deep ulcerations of diabetic foot. Diabet Med 18(4):320–324 (in Eng). https://doi.org/10.1046/j.1464-5491.2001.00466.x
doi: 10.1046/j.1464-5491.2001.00466.x
pubmed: 11437864
Tonaco LAB, Gomes FL, Velasquez-Melendez G, Lopes MTP, Salas CE (2018) The proteolytic fraction from latex of vasconcellea cundinamarcensis (P1G10) enhances wound healing of diabetic foot ulcers: a double-blind randomized pilot study. Adv Ther 35(4):494–502 (in Eng). https://doi.org/10.1007/s12325-018-0684-2
doi: 10.1007/s12325-018-0684-2
pubmed: 29564750
Jonker L, Smith D, Mark E, Thornthwaite S, Gunn C, Fisher S (2021) A pragmatic, single-center, prospective, randomized controlled trial of adjunct hemoglobin-mediated granulox topical oxygen therapy twice weekly for foot ulcers. J Am Podiatr Med Assoc 2021;111(5) (in Eng). https://doi.org/10.7547/19-189 .
Lee M, Han SH, Choi WJ, Chung KH, Lee JW (2016) Hyaluronic acid dressing (Healoderm) in the treatment of diabetic foot ulcer: a prospective, randomized, placebo-controlled, single-center study. Wound Repair Regen 24(3):581–588 (in Eng). https://doi.org/10.1111/wrr.12428
doi: 10.1111/wrr.12428
pubmed: 26972358
Veves A, Sheehan P, Pham HT (2002) A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg 137(7):822–827 (in Eng). https://doi.org/10.1001/archsurg.137.7.822
doi: 10.1001/archsurg.137.7.822
pubmed: 12093340
Edmonds ME, Bodansky HJ, Boulton AJM et al (2018) Multicenter, randomized controlled, observer-blinded study of a nitric oxide generating treatment in foot ulcers of patients with diabetes-ProNOx1 study. Wound Repair Regen 26(2):228–237 (in Eng). https://doi.org/10.1111/wrr.12630
doi: 10.1111/wrr.12630
pubmed: 29617058
Armstrong DG, Tan TW, Boulton AJM, Bus SA (2023) Diabetic foot ulcers: a review. JAMA 330(1):62–75 (in Eng). https://doi.org/10.1001/jama.2023.10578
doi: 10.1001/jama.2023.10578
pubmed: 37395769
Yildiz Karadeniz E, Kaplan SE (2023) Use of honey in diabetic foot ulcer: Systematic review and meta-analysis. J Tissue Viability 32(2):270–278 (in Eng). https://doi.org/10.1016/j.jtv.2023.03.002
doi: 10.1016/j.jtv.2023.03.002
pubmed: 37032304
Dissemond J, Böttrich JG, Braunwarth H, Hilt J, Wilken P, Münter KC (2017) Evidence for silver in wound care—meta-analysis of clinical studies from 2000–2015. J Dtsch Dermatol Ges 15(5):524–535 (in Eng). https://doi.org/10.1111/ddg.13233
doi: 10.1111/ddg.13233
pubmed: 28485879
Elraiyah T, Tsapas A, Prutsky G et al (2016) A systematic review and meta-analysis of adjunctive therapies in diabetic foot ulcers. J Vasc Surg 63(2 Suppl):46S-58S.e1–2 (in Eng). https://doi.org/10.1016/j.jvs.2015.10.007 .
Wang Y, Chao N, Yin D (2022) A net meta-analysis of the effectiveness of different types of dressings in the treatment of diabetic foot. Comput Math Methods Med 2022:4915402 (in Eng). https://doi.org/10.1155/2022/4915402
doi: 10.1155/2022/4915402
pubmed: 35898487
pmcid: 9313931
Dumville JC, Deshpande S, O'Meara S, Speak K (2013) Hydrocolloid dressings for healing diabetic foot ulcers. Cochrane Database Syst Rev 2013(8):Cd009099 (in Eng). https://doi.org/10.1002/14651858.CD009099.pub3 .
Zhang C, Zhang S, Wu B, Zou K, Chen H (2023) Efficacy of different types of dressings on pressure injuries: systematic review and network meta-analysis. Nurs Open 10(9):5857–5867 (in Eng). https://doi.org/10.1002/nop2.1867
doi: 10.1002/nop2.1867
pubmed: 37386783
pmcid: 10416006
Gauna C, Romeo F, Scatena A et al (2024) Offloading systems for the treatment of neuropathic foot ulcers in patients with diabetes mellitus: a meta-analysis of randomized controlled trials for the development of the Italian guidelines for the treatment of diabetic foot syndrome. Acta Diabetol (in Eng). https://doi.org/10.1007/s00592-024-02262-9
doi: 10.1007/s00592-024-02262-9
pubmed: 38565687
Chen P, Vilorio NC, Dhatariya K et al (2024) Guidelines on interventions to enhance healing of foot ulcers in people with diabetes (IWGDF 2023 update). Diabetes Metab Res Rev 40(3):e3644 (in Eng). https://doi.org/10.1002/dmrr.3644
doi: 10.1002/dmrr.3644
pubmed: 37232034